Cargando…
Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations()
We report the characteristics of relapse, treatment response, and outcomes of 145 elderly patients with multiple myeloma in first relapse after front-line treatment with VMP or VTP. Reappearance of CRAB symptoms (113 patients) and more aggressive forms of disease (32 patients) were the most common p...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588395/ https://www.ncbi.nlm.nih.gov/pubmed/26500850 http://dx.doi.org/10.1016/j.lrr.2015.09.002 |
_version_ | 1782392616649752576 |
---|---|
author | Lopez, Aurelio Mateos, Maria-Victoria Oriol, Albert Valero, Marta Martínez, Joaquín Lorenzo, Jose Ignacio Perez, Montserrat Martinez, Rafael de Paz, Raquel Granell, Miguel De Arriba, Felipe Blanchard, M. Jesús Peñalver, Francisco Javier Bello, Jose Luis Martin, Maria Luisa Bargay, Joan Blade, Joan Lahuerta, Juan Jose San Miguel, Jesús F. de la Rubia, Javier |
author_facet | Lopez, Aurelio Mateos, Maria-Victoria Oriol, Albert Valero, Marta Martínez, Joaquín Lorenzo, Jose Ignacio Perez, Montserrat Martinez, Rafael de Paz, Raquel Granell, Miguel De Arriba, Felipe Blanchard, M. Jesús Peñalver, Francisco Javier Bello, Jose Luis Martin, Maria Luisa Bargay, Joan Blade, Joan Lahuerta, Juan Jose San Miguel, Jesús F. de la Rubia, Javier |
author_sort | Lopez, Aurelio |
collection | PubMed |
description | We report the characteristics of relapse, treatment response, and outcomes of 145 elderly patients with multiple myeloma in first relapse after front-line treatment with VMP or VTP. Reappearance of CRAB symptoms (113 patients) and more aggressive forms of disease (32 patients) were the most common patterns of relapse. After second-line therapy, 75 (51.7%) patients achieved at partial response and 16 (11%) complete response (CR). Overall survival was longer among patients receiving VMP as front-line induction (21.4 vs. 14.4 months, P=0.037), in patients achieving CR (28.3 vs. 14.8 months; P=0.04), and in patients without aggressive relapse (28.6 vs. 7.6 months; P=0.0007). |
format | Online Article Text |
id | pubmed-4588395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-45883952015-10-23 Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations() Lopez, Aurelio Mateos, Maria-Victoria Oriol, Albert Valero, Marta Martínez, Joaquín Lorenzo, Jose Ignacio Perez, Montserrat Martinez, Rafael de Paz, Raquel Granell, Miguel De Arriba, Felipe Blanchard, M. Jesús Peñalver, Francisco Javier Bello, Jose Luis Martin, Maria Luisa Bargay, Joan Blade, Joan Lahuerta, Juan Jose San Miguel, Jesús F. de la Rubia, Javier Leuk Res Rep Case Report We report the characteristics of relapse, treatment response, and outcomes of 145 elderly patients with multiple myeloma in first relapse after front-line treatment with VMP or VTP. Reappearance of CRAB symptoms (113 patients) and more aggressive forms of disease (32 patients) were the most common patterns of relapse. After second-line therapy, 75 (51.7%) patients achieved at partial response and 16 (11%) complete response (CR). Overall survival was longer among patients receiving VMP as front-line induction (21.4 vs. 14.4 months, P=0.037), in patients achieving CR (28.3 vs. 14.8 months; P=0.04), and in patients without aggressive relapse (28.6 vs. 7.6 months; P=0.0007). Elsevier 2015-09-24 /pmc/articles/PMC4588395/ /pubmed/26500850 http://dx.doi.org/10.1016/j.lrr.2015.09.002 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Lopez, Aurelio Mateos, Maria-Victoria Oriol, Albert Valero, Marta Martínez, Joaquín Lorenzo, Jose Ignacio Perez, Montserrat Martinez, Rafael de Paz, Raquel Granell, Miguel De Arriba, Felipe Blanchard, M. Jesús Peñalver, Francisco Javier Bello, Jose Luis Martin, Maria Luisa Bargay, Joan Blade, Joan Lahuerta, Juan Jose San Miguel, Jesús F. de la Rubia, Javier Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations() |
title | Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations() |
title_full | Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations() |
title_fullStr | Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations() |
title_full_unstemmed | Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations() |
title_short | Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations() |
title_sort | patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations() |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588395/ https://www.ncbi.nlm.nih.gov/pubmed/26500850 http://dx.doi.org/10.1016/j.lrr.2015.09.002 |
work_keys_str_mv | AT lopezaurelio patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT mateosmariavictoria patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT oriolalbert patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT valeromarta patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT martinezjoaquin patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT lorenzojoseignacio patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT perezmontserrat patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT martinezrafael patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT depazraquel patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT granellmiguel patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT dearribafelipe patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT blanchardmjesus patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT penalverfranciscojavier patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT bellojoseluis patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT martinmarialuisa patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT bargayjoan patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT bladejoan patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT lahuertajuanjose patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT sanmigueljesusf patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations AT delarubiajavier patternsofrelapseandoutcomeofelderlymultiplemyelomapatientstreatedasfrontlinetherapywithnovelagentscombinations |